Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29843605 | 1.00 | LMNA (0.72) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL28724453 | 1.00 | LMNA (0.72) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL1269942 | 1.00 | LMNA (0.72) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL2702380 | 0.97 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| Potassium SCHEMBL31152547 | 0.97 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| Methane SCHEMBL28448557 | 0.97 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL29588198 | 0.97 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL10866519 | 0.97 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL9542319 | 0.97 | LMNA (0.78) | LMNABLMPTPN1MEN1CYP3A4 | |
| Bromide SCHEMBL28288587 | 0.97 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1017 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122047683-A | Oil well production initial yield splitting method based on logging gas chromatography data, electronic equipment and medium | 中国石油集团渤海钻探工程有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026087246-A1 | BIOTECHNOLOGICAL PRODUCTION OF PHYTOL | BASF SE (DE) | 2026-04-30 | — | — | WO | claimed |
| US-20250248400-A1 | NANOPARTICULATE FORMULATION FOR PREVENTING OR TREATING CALLOSE FORMATION IN PLANTS | PURDUE RESEARCH FOUNDATION (US) | 2025-08-07 | — | — | US | claimed |
| CN-120036318-A | Curved line purple gray butterfly attractant composition and application thereof | 广西大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119613744-A | Degradable film material and preparation method thereof | 南京工业大学 | 2025-03-14 | — | — | CN | claimed |
| EP-4364720-B1 | OXIDATIVE HAIR TREATMENT COMPOSITIONS | WELLA GERMANY GMBH (DE) | 2025-02-19 | — | — | EP | claimed |
| CN-119108054-A | Novel sea-phase mixed accumulation type shale hydrocarbon production potential evaluation method and system | 成都理工大学 | 2024-12-10 | — | — | CN | claimed |
| CN-119104580-A | High-precision recovery method and system for judging sea-phase mixed-accumulation shale deposition environment | 西南石油大学 | 2024-12-10 | — | — | CN | claimed |
| CN-119013012-A | Pharmaceutical composition for treating heart failure accompanied by diastolic dysfunction | 国立大学法人东海国立大学机构 | 2024-11-22 | — | — | CN | claimed |
| CN-118671219-A | Method for recovering hydrocarbons in dense core | 中国石油大学(北京) | 2024-09-20 | — | — | CN | claimed |
| EP-1667656-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | FH Faulding & Co. Limited (AU) | 2006-06-14 | — | — | EP | claimed |
| CN-1258088-C | Method for identifying real and false oil/gas display using drilling well liquid pyrolyzation-gas phase chromatography logging well | DAQING OIL FIELD CO LTD (CN) | 2006-05-31 | — | — | CN | claimed |
| US-20060014647-A1 | Synthetic base fluid for enhancing the results of crude oil characterization analyses | BAKER HUGHES INCORPORATED (US) | 2006-01-19 | — | — | US | claimed |
| US-20050249665-A1 | Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants | DBL AUSTRALIA PTY LTD. (AU) | 2005-11-10 | — | — | US | claimed |
| CN-1694865-A | Urea, glycerate and hydroxylamine headed hydrocarbon chain lyotropic phase forming surfactants | DBL AUSTRALIA PTY LTD (AU) | 2005-11-09 | — | — | CN | claimed |
| WO-2005021046-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | FH FAULDING & CO LTD (AU) | 2005-03-10 | — | — | WO | claimed |
| CN-1588038-A | Method for identifying real and false oil/gas display using drilling well liquid pyrolyzation-gas phase chromatography logging well | DAQING OIL FIELD CO LTD (CN) | 2005-03-02 | — | — | CN | claimed |
| US-20030119679-A1 | Synthetic base fluid for enhancing the results of crude oil characterization analyses | BAKER HUGHES INCORPORATED | 2003-06-26 | — | — | US | claimed |
| US-6514915-B1 | Synthetic base fluid for enhancing the results of crude oil characterization analyses | BAKER HUGHES INCORPORATED | 2003-02-04 | — | — | US | claimed |
| US-5443840-A | Aqueous dispersion phase of lipid vesicles comprising lipid phase containing ionic or nonionic amphiphilic lipid, polyol or isoprenoic acid containing phytyl chain | L'OREAL (FR) | 1995-08-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050249665-A1 | Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants | LIPA, HDHD5, UGCG | LMNA 208/4885BLM 1559/4885PTPN1 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.